Related Experiment Video
Updated: Oct 21, 2025

09:33
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.1K
Innate Immunity Protein IFITM3 in Alzheimer's Disease
1Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
DNA and Cell Biology
|September 1, 2021
Summary
Innate immunity influences Alzheimer's disease (AD) by modulating amyloid-beta (Aβ) production through the antiviral protein IFITM3 and γ-secretase. This pathway contributes to AD pathogenesis.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Alzheimer's disease (AD) is linked to innate immunity genes.
- The role of innate immunity in amyloid-beta (Aβ) production was previously unclear.
Purpose of the Study:
- To review mechanisms of innate immunity in modulating Aβ production.
- To explore the contribution of IFITM3-γ-secretase complexes to AD pathogenesis.
Main Methods:
- Literature review of innate immunity genes in AD.
- Analysis of IFITM3 as a γ-secretase modulator.
- Discussion of molecular mechanisms.
Main Results:
- Interferon-induced transmembrane protein 3 (IFITM3) identified as a novel γ-secretase modulatory protein.
- IFITM3 influences Aβ production, a key component of AD pathology.
- Innate immunity pathways can impact amyloid plaque formation.
Conclusions:
- Innate immunity, via IFITM3, plays a significant role in regulating Aβ production.
- Understanding these mechanisms offers new insights into AD pathogenesis.
- Targeting IFITM3-γ-secretase interactions may present therapeutic strategies for AD.
Related Concept Videos
Alzheimer's Disease: Overview
770
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
770
Role of Neurotransmitters in Memory
1.6K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
1.6K
Alzheimer's Disease: Treatment
314
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
314
Amyloid Fibrils
10.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.8K

